In rat trachea, two types of mast cells have been identified, connective ti
ssue mast cells (CTMCs) and mucosal mast cells (MMCs). We previously report
ed that CTMCs play an important role in tracheal contraction in vitro via 5
-hydroxytryptamine (5-HT) release in a rat model. In this study, we investi
gated whether MMCs also play a role in tracheal contraction by employing ma
st cell-deficient (Ws/Ws) rats and their congenic (+/+) rats. Rats were act
ively sensitized with ovalbumin and challenged with it 2 weeks later. To ex
clude the influence of CTMCs, rats were pretreated for 7 days with compound
48/80 injected i.p. in increasing doses. Histological study confirmed that
degranulation occurred in CTMCs, but MMCs still remained. Histamine levels
in trachea decreased to 9.31% of control levels. Ovalbumin-specific IgE pr
oduction showed a time-dependent increase in both Ws/Ws and +/+ rats after
sensitization with no significantly different values between the two groups
. Ovalbumin challenge caused contraction of the trachea in sensitized contr
ol (+/+) rats, but not in sensitized Ws/Ws and compound 48/80-pretreated +/
+ rats. Ketanserin inhibited the contraction, but leukotriene antagonist ON
O-1078 did not, indicating that the contraction was due to 5-HT, whereas le
ukotriene, a mediator specific derived from MMCs, has no significant effect
. The results suggest that MMCs has minimal, if any, contribution to trache
al contraction and might have another function. Furthermore, Ws/Ws and the
congenic rats provide a good model for studying the role of mast cells in t
he immunologic response in airways.